Table 1.
Gestational age (weeks + d) | sVEGFR-1 (pg/mL) (percentile) | PlGF (pg/mL) (percentile) | sEng (ng/mL) (percentile) | PlGF/s VEGFR-1 (percentile) |
---|---|---|---|---|
13+3 | 5664 (98th) | 60 (59th) | 9.8 (96th) | 0.01 (4th) |
15+4 | 4897 (98th) | 100 (60th) | 11.8 (98th) | 0.02 (6th) |
17+4 | 4480 (96th) | 157 (62th) | 11.3 (98th) | 0.03 (10th) |
19+5 | 4148 (93th) | 306 (76th) | 13.1 (98th) | 0.07 (23th) |
21+6 | 1889 (56th) | 644 (93th) | 8.7 (94th) | 0.34 (90th) |
25+3 | 2854 (80th) | 768 (79th) | 8.8 (94 th) | 0.27 (51th) |
27+4 | 3881 (90th) | 869 (74th) | 9.9 (95th) | 0.22 (34th) |
29+4 | 4684 (93th) | 821 (65th) | 12.7 (97th) | 0.18 (25th) |
31+4 | 6370 (97th) | 536 (44th) | 9.6 (85th) | 0.08 (10th) |
33+5 | 11202 (99th) | 528 (46th) | 12.7 (85th) | 0.04 (6th) |
sVEGFR-1, soluble vascular endothelial growth factors receptor-1; PlGF, placental growth factor; sEng, soluble endoglin.
Percentile distribution was based on a published reference range [20].